QUANTERIX CORP (QTRX) Stock News
NASDAQ:QTRX - Nasdaq - US74766Q1013 - Common Stock - Currency: USD
QTRX Latest News, Press Relases and Analysis
Quanterix Expands Reach with IVD and Large Reference Labs
Quanterix to Present at Goldman Sachs Global Healthcare Conference
Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal
/PRNewswire/ -- Kent Lake PR LLC ("Kent Lake"), a holder of approximately 6.9% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the...
Mentions: AKYA
Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates
Quanterix (QTRX) delivered earnings and revenue surprises of 23.19% and 8.99%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: MDT
Quanterix Releases Financial Results for the First Quarter of 2025
Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates
Phibro (PAHC) delivered earnings and revenue surprises of 21.15% and 0.78%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: PAHC
Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025
Kent Lake Issues Statement on Quanterix’s Blatant Disregard for Will of Shareholders
Quanterix and Akoya Biosciences Announce Amended Merger Agreement
Mentions: AKYA
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders
Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders
Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya
Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit
Quanterix Releases Financial Results for the Fourth Quarter of 2024
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
Mentions: AKYA
Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025
Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix’s Proposed Merger with Akoya Biosciences
Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board
Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition
Bragar Eagel & Squire, P.C. Is Investigating Quanterix, e.l.f. Beauty, and Silvaco and Encourages Investors to Contact the Firm
QTRX Investor News: Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IVAC, AVTE, QTRX on Behalf of Shareholders
